Actively Recruiting
Study of Post-transplant Thrombotic Microangiopathy Outcomes in Kidney Transplant Patients at Bologna Centre
Led by IRCCS Azienda Ospedaliero-Universitaria di Bologna · Updated on 2025-01-06
250
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
This research aims to evaluate the occurrence of post-transplant thrombotic microangiopathy PT-TMA in patients who have received kidney transplants and to understand how this condition affects kidney transplant outcomes. The study collects and analyzes clinical information from a large group of kidney transplant patients to determine the incidence of PT-TMA and its impact on transplant success. The study involves both retrospective and prospective data collection. Retrospective data from patients diagnosed with PT-TMA starting June 1, 2016, until study approval are systematically gathered. After approval, prospective data collection will continue for 10 years. Patients enrolled prospectively will receive treatment following standard clinical practice, guided by their physicians. Participants clinical data will be collected and monitored at various times after transplantation, including 15 days, 1 month, 6 months, and then every 6 months thereafter. Researchers will track the incidence of PT-TMA and assess kidney graft outcomes over time. This study is observational and non-drug based, focusing on gathering valuable information for scientific and health protection purposes.
CONDITIONS
Brief Title
Post-transplant Thrombotic Microangiopathy: Evaluation of Outcomes at the Bologna Kidney Transplant Centre
Research Team
M
MARCELLO DEMETRI, BIOLOGY
G
Giorgia Comai, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here